Table 4.
Results of outcome measures assessed in the pilot RCT
| Outcome measure | Standard care (n = 6) |
Intervention (n = 10) |
||||
|---|---|---|---|---|---|---|
| Baseline | Completion | Change | Baseline | Completion | Change | |
| ISWT (m) | 20.0 (10.0 to 60.0) | 190.0 (70.0 to 355.0) | 170.0 (40.0 to 315.0) | 55.0 (7.8 to 120.0) | 200.0 (132.5 to 340.0) | 115.0 (− 2.5 to 237.5) |
| 6MWT (m) | 150.0 (100.5 to 207.0) | 335.0 (177.5 to 455.0) | 185.0 (40.0 to 285.0) | 180.0 (125.0 to 221.5) | 328.5 (230.0 to 393.8) | 140.0 (35.8 to 210.3) |
| SF-36 v2 PCS (/100) | 20.6 (19.4 to 33.3) | 42.3 (27.9 to 47.6) | 11.0 (4.3 to 28.3) | 29.8 (24.1 to 33.2) | 33.2 (23.8 to 45.4) | 1.8 (− 6.8 to 15.9) |
| SF-36 v2 MCS (/100) | 50.9 (35.6 to 57.8) | 45.6 (34.3 to 54.7) | − 11.4 (− 19.0 to 19.1) | 31.6 (28.6 to 49.1) | 53.4 (39.5 to 58.8) | 14.3 (− 3.2 to 26.7) |
| HADS total (/42) | 14.0 (9.0 to 20.0) | 6.5 (5.5 to 10.3) | − 4.5 (− 13.3 to − 2.5) | 13.0(7.0 to 19.0) | 9.0 (3.5 to 10.3) | − 6 (− 9.3 to − 2.8) |
| HADS anxiety (/21) | 6.0 (1.5 to 11.5) | 4.0 (0.8 to 6.0) | 0.0 (− 7.0 to 0.0) | 7.0 (4.5 to 9.3) | 4.0 (1.8 to 5.5) | − 3.5 (− 5.0 to − 1.3) |
| HADS depression (/21) | 8.5 (7.3 to 10.0) | 2.5 (2.0 to 8.0) | − 4.5 (− 6.3 to − 1.8) | 5.5 (2.8 to 11.0) | 4.5 (1.0 to 7.3) | − 1.5 (− 3.3 to 2.0) |
Data are presented as median (IQR).